|
CA3003780A1
|
|
Delivering osmolytes by nasal cannula
|
|
CA2984424A1
|
|
Novel prodrugs of dithiol mucolytic agents
|
|
WO2016133967A2
|
|
Sodium channel blockers for skin disorders
|
|
AU2016211440A1
|
|
Novel monothiol mucolytic agents
|
|
US2015376145A1
|
|
Stable sodium channel blockers
|
|
AU2014221224A1
|
|
Delivering osmolytes by nasal cannula
|
|
CA2922162A1
|
|
Dithiol mucolytic agents
|
|
CA2896686A1
|
|
3,5-diamino-6-chloro-n-(n-(4-phenylbutyl)carbamimidoyl) pyrazine-2- carboxamide compounds
|
|
US2015166487A1
|
|
Arylalkyl- and aryloxyalkyl-substituted epithelial sodium channel blocking compounds
|
|
MX2015007797A
|
|
3,5-diamino-6-chloro-n-(n-(4-phenylbutyl)carbamimidoyl) pyrazine-2- carboxamide compounds.
|
|
US2014171447A1
|
|
Chloro-pyrazine carboxamide derivatives with epithelial sodium channel blocking activity
|
|
EP2928532A1
|
|
Nasal cannula for delivery of aerosolized medicaments
|
|
WO2014036445A2
|
|
Novel mucolytic agents
|
|
WO2013181232A2
|
|
Dendrimer like amino amides possessing sodium channel blocker activity for the treatment of dry eye and other mucosal diseases
|
|
US2014109899A1
|
|
Aerosol delivery systems, compositions and methods
|
|
AU2013200821A1
|
|
Heteroaromatic pyrazinoylguanidine sodium channel blockers
|
|
BR112013032771A2
|
|
chemically and metabolically stable dipeptide having potent sodium channel blocking activity
|
|
AR086745A1
|
|
3,5-DIAMINO-6-CHLORINE-N- (N- (4- (4- (2- (HEXIL (2,3,4,5,6-PENTAHYDROXIHEXIL)) AMINO) ETOXI) PHENYL) BUTIL) CARBAMIMIDOIL) PIRAZINA -2-CARBOXAMIDE
|
|
EP2717855A1
|
|
Methods of treatment
|
|
AU2012201188A1
|
|
New capped pyrazinoylguanidine sodium channel blockers
|
